Form 4: Opus Genetics Director Richard J. Rodgers Acquires Shares and Options

Director Richard J. Rodgers acquired 79,504 shares of common stock and options to purchase 79,592 shares of common stock in Opus Genetics, Inc. on April 30, 2025.

Summary

• On April 30, 2025, Richard J. Rodgers, a director of Opus Genetics, Inc., acquired 79,504 shares of common stock.
• These shares were granted as restricted stock units.
• Rodgers also acquired options to purchase 79,592 shares of common stock at an exercise price of $0.95.
• The restricted stock units and options vest upon the earlier of one year from the grant date or the day before the next annual meeting of stockholders, contingent on continued service.
• Following these transactions, Rodgers directly owns 318,655 shares of Opus Genetics, Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a positive sign of confidence but doesn't inherently guarantee future performance.

Positives

• The acquisition of shares and options by a director signals confidence in the company's future prospects.

Future Outlook

The vesting of the restricted stock units and options is tied to the director's continued service, incentivizing long-term commitment to the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The transaction could positively influence shareholder sentiment due to the director's increased stake in the company.

Key Dates

Keywords

Opus Genetics, Richard J. Rodgers, Director, Stock Options, Restricted Stock Units, Beneficial Ownership, Form 4, IRD